BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32219953)

  • 1. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
    Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
    Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for Fontan-associated hepatocellular carcinoma.
    Kogiso T; Sagawa T; Taniai M; Shimada E; Inai K; Shinohara T; Tokushige K
    PLoS One; 2022; 17(6):e0270230. PubMed ID: 35714161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.
    Onishi H; Toh N; Akagi T; Baba K; Kotani Y; Takaki A; Kasahara S; Ito H
    Clin J Gastroenterol; 2024 Feb; 17(1):148-154. PubMed ID: 38032452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
    Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
    Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
    Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
    Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
    Possner M; Gordon-Walker T; Egbe AC; Poterucha JT; Warnes CA; Connolly HM; Ginde S; Clift P; Kogon B; Book WM; Walker N; Wagenaar LJ; Moe T; Oechslin E; Kay WA; Norris M; Dillman JR; Trout AT; Anwar N; Hoskoppal A; Broering DC; Bzeizi K; Veldtman G
    Int J Cardiol; 2021 Jan; 322():142-148. PubMed ID: 32828959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021.
    Ohfuji S; Tanaka A; Kogiso T; Kanto T
    Hepatol Res; 2024 Mar; ():. PubMed ID: 38526972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
    Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
    J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series.
    Feeley M; Hopkins K; Grinspan LT; Schiano T; Love B; Chan A; Lewis S; Zaidi AN
    Pediatr Cardiol; 2023 Oct; 44(7):1447-1453. PubMed ID: 37318608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fontan-associated liver disease and hepatocellular carcinoma in adults.
    Kogiso T; Tokushige K
    Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery.
    Sakamori R; Yamada R; Tahata Y; Kodama T; Hikita H; Tatsumi T; Yamada T; Takehara T
    J Gastroenterol; 2022 Feb; 57(2):111-119. PubMed ID: 35064829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fontan-associated liver disease: A review.
    Gordon-Walker TT; Bove K; Veldtman G
    J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report.
    Hur MH; Kim H; Lee JH
    J Liver Cancer; 2022 Sep; 22(2):188-193. PubMed ID: 37383407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Emphasis on Screening to Detect Liver Cirrhosis and Hepatocellular Carcinoma in Patients Having Undergone the Fontan Procedure in Early Childhood.
    Madala S; MacDougall K; Polavarapu A; Gurala D; Gumaste V; Morvillo G
    Case Rep Gastroenterol; 2020; 14(3):615-623. PubMed ID: 33362449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fontan-Associated Liver Disease: A Review.
    Heering G; Lebovics N; Agarwal R; Frishman WH; Lebovics E
    Cardiol Rev; 2024 Mar; ():. PubMed ID: 38477576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign Hepatic Nodules Mimicking Hepatocellular Carcinoma in the Setting of Fontan-associated Liver Disease: A Case Report.
    Çolaklar A; Lehnert SJ; Tirkes T
    Euroasian J Hepatogastroenterol; 2020; 10(1):42-44. PubMed ID: 32742972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance.
    Yoon JS; Lee DH; Cho EJ; Song MK; Choi YH; Kim GB; Lee YB; Lee JH; Yu SJ; Kim H; Kim YJ; Yoon JH; Bae EJ
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Fontan-Associated Liver Disease and Its Association With Mortality.
    Guerrero-Chalela CE; Therrien J; Grossman Y; Guo L; Liu A; Marelli A
    J Am Heart Assoc; 2023 Oct; 12(19):e024034. PubMed ID: 37776221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.